8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Sep 16, 2024 · 1y ago · Accession 0001193125-24-219180
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Sep 16, 2024
- Report date
- Sep 14, 2024
- Document
- d355136d8k.htm
- Size
- 6.4 MB